Supplemental material
Report
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
Brian C. Macknessa Biologics Research, Sanofi, Framingham, MA, USACorrespondence[email protected]
https://orcid.org/0000-0002-3587-5603View further author information
https://orcid.org/0000-0002-3587-5603View further author information, Julie A. Jaworskia Biologics Research, Sanofi, Framingham, MA, USAhttps://orcid.org/0000-0002-0633-287XView further author information
https://orcid.org/0000-0002-0633-287XView further author information, , Anna Parka Biologics Research, Sanofi, Framingham, MA, USAhttps://orcid.org/0000-0002-6511-8363View further author information
https://orcid.org/0000-0002-6511-8363View further author information, , , , Thorsten Schmidtc Biologics Research, Sanofi, Frankurt, Germanyhttps://orcid.org/0000-0001-9952-8881View further author information
https://orcid.org/0000-0001-9952-8881View further author information, , Abdullah Kandirad Translational Models, Sanofi, Frankurt, Germanyhttps://orcid.org/0000-0001-9822-6136View further author information
https://orcid.org/0000-0001-9822-6136View further author information, Katarina Radoševiće Biologics Research, Sanofi, Vitry-Sur-Seine, Francehttps://orcid.org/0000-0002-6769-8402View further author information
https://orcid.org/0000-0002-6769-8402View further author information & show all